Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

The Great Vitamin Scam: How Orrin Hatch Hijacked Your Health


Buying the right politician can do more for a brand than any amount of marketing.


One might imagine the tentacles of the Functional Food/Nutritional Supplement/Orrin Hatch vampire squid couldn't possibly reach any further.

But they do.

Remember Loren Israelson's United Natural Products Alliance?

Well, the Alliance hires lobbyists, too.

One of the lobbying firms is called Knight Capitol Consultants, and is run by a woman named Patricia Knight.

Ms. Knight also happens to be on the board of the UNPA, as a Senior Political Advisor. Here's her bio, as seen on the UNPA website:

Patricia Knight left three decades of government service in 2007 to found a small Washington, D.C.-based consulting business providing strategic advice on a range of health-care issues, with an emphasis on those that are FDA-related. Trisha has had a long association with health care policy and legislation, particularly that involving dietary supplements. She served as Health Policy Director and later Chief of Staff to Senator Orrin G. Hatch (R-UT) for 15 years. In that position, she was responsible for directing all aspects of the Senator's office, including policy, legislative development, staffing and administration.

The UNPA retains a second lobbying outfit, called Reinecke Strategic Solutions, Inc., which is run by a fellow named Peter Reinecke.

He also happens to be a UNPA board member, as a Senior Political Advisor, as well. Reinecke's bio, as seen on the UNPA website, reads as follows:

Peter Reinecke, principal of Reinecke Strategic Solutions, Inc., serves as Senior Advisor to UNPA. For 25 years, Peter has been a leader in health and nutrition policy having spent over 20 years working for the U.S. Congress. As staff to the Senate Health, Education, Labor and Pensions Committee and as Legislative Director and Chief of Staff to Senator Tom Harkin, he helped write many key pieces of health legislation, including the establishment of the National Center for Complementary and Alternative Medicine at NIH and the Dietary Supplement Health and Education Act (DSHEA).

Cozy, huh?

In any case, whether or not you choose to believe POM Wonderful's disputed claims, there is one fact that no one is arguing.

Pomegranates do contain large amounts of antioxidants -- which could interfere with certain drugs, like Crestor (AZN) and Lipitor (PFE).

Furthermore, overloading the system with antioxidants may actually have a negative effect on the body -- the free-radicals they attack spur the body to activate growth factors that, in turn, increase levels of ''important enzymes associated with cell defense'' and ''adaptation to exercise,'' according to researchers. As it turns out, ''the practice of taking antioxidants'' to prevent free-radical damage ''may have to be re-evaluated.''

So, the entire equation may have collapsed right there. Suffice it to say, you won't find that information on the side of your POM bottle, and you can thank Senator Orrin Hatch, Utah, for that.

Follow the markets all day every day with a FREE 14 day trial to Buzz & Banter. Over 30 professional traders share their ideas in real-time. Learn more.

No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos